KIP Stock Overview
Kolinpharma S.p.A. operates as a nutraceuticals company in Italy.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Kolinpharma S.p.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €9.90 |
52 Week High | €10.00 |
52 Week Low | €6.98 |
Beta | 0.65 |
11 Month Change | 0% |
3 Month Change | -0.50% |
1 Year Change | 22.83% |
33 Year Change | 22.22% |
5 Year Change | 56.47% |
Change since IPO | 41.65% |
Recent News & Updates
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital
Jun 17What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?
Dec 01Recent updates
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital
Jun 17What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?
Dec 01An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued
Aug 25We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt
Jun 08Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?
May 21Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?
May 03Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio
Apr 13What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?
Feb 20Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Dec 28These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well
Nov 22Shareholder Returns
KIP | IT Personal Products | IT Market | |
---|---|---|---|
7D | 0% | -2.9% | -3.1% |
1Y | 22.8% | 7.6% | 17.9% |
Return vs Industry: KIP exceeded the Italian Personal Products industry which returned 7.4% over the past year.
Return vs Market: KIP exceeded the Italian Market which returned 17.6% over the past year.
Price Volatility
KIP volatility | |
---|---|
KIP Average Weekly Movement | 1.1% |
Personal Products Industry Average Movement | 4.5% |
Market Average Movement | 4.1% |
10% most volatile stocks in IT Market | 6.7% |
10% least volatile stocks in IT Market | 2.5% |
Stable Share Price: KIP has not had significant price volatility in the past 3 months.
Volatility Over Time: KIP's weekly volatility (1%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | 107 | Rita Petrelli | www.kolinpharma.com |
Kolinpharma S.p.A. operates as a nutraceuticals company in Italy. The company engages in the development and marketing of food supplements. It provides multivitamins, energizers and dietetics, and drugs.
Kolinpharma S.p.A. Fundamentals Summary
KIP fundamental statistics | |
---|---|
Market cap | €15.91m |
Earnings (TTM) | €342.34k |
Revenue (TTM) | €15.62m |
46.5x
P/E Ratio1.0x
P/S RatioIs KIP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
KIP income statement (TTM) | |
---|---|
Revenue | €15.62m |
Cost of Revenue | €7.39m |
Gross Profit | €8.23m |
Other Expenses | €7.89m |
Earnings | €342.34k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0.21 |
Gross Margin | 52.71% |
Net Profit Margin | 2.19% |
Debt/Equity Ratio | 105.3% |
How did KIP perform over the long term?
See historical performance and comparison